E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPACEI1816(ACE-inhibitory peptide)
DFBP ID DFBPACEI1816
Peptide sequence VVAPFPE
Type Native peptide
Peptide/Function name ACE-inhibitory peptide
Function-activity relationship
Main bioactivity ACE-inhibitory activity
Otheir bioactivity Antimicrobial activity [D1], Multifunctional activity [D2]
Calculated physicochemical properties
Three-letter amino acid Val-Val-Ala-Pro-Phe-Pro-Glu
Single-letter amino acid VVAPFPE
Peptide length 7
Peptide mass
Experimental mass Theoretical mass
757.4 Da 757.88 Da c
Net charge 0.00 c
Isoelectric point (pI) 3.34 c
IC50 N.D
pIC50 N.D
GRAVY 0.9000 c
Hydrophilic residue ratio 85.71% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Manchego cheeses, Ovine milk protein
Precursor protein αs1-Casein
Residue position

f(24-30)

Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
ACE-inhibitory activity

The fraction F6.4 of water-soluble extracts from Manchego cheeses (containing peptide VVAPFPE) showed potent Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) inhibitory activity, so the peptide was a potential ACE-inhibitory peptide, as shown in Table 1.

Table 1. Identification of the peptides contained in the analytical RP-HPLC fractions with ACE-inhibitory activity
Fraction
Protein fragment
Sequence
Protein content (μg/mL) a
% ACE inhibition a
F6.4
αs1-casein f(24-30)VVAPFPE
37.9 ± 0.3
100.0 ± 0.1
αs1-casein f(102-109)KKYNVPQL
β-casein f(197-204)GPVRGPFP
a Average values ± standard deviation (n = 3).
Specific target protein(s) Specific Target Protein(s):
Angiotensin-converting enzyme
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(C)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)O
Preparation method
Mode of preparation

Fermentation

Enzyme(s)/starter culture

The peptide was isolated from the water-soluble extract of a ripened Manchego cheese (Type 1: Expermental batches of pasteurised-milk cheeses was prepared by inoculating milk with Lactococcus lactis subsp. lactis (80%) and Leuconostoc mesenteroides subsp. dextranicum (20%)).

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information

The potential of the peptide for its use in functional foods to mitigate hypertension would seem to merit further investigation using animal in vivo assays.

Database cross-references
DFBP
[D1] DFBPAMIC0178
[D2] DFBPMUFU0538
BIOPEP-UWM [D3] -
APD [D4] -
BioPepDB [D5] -
MBPDB [D6] -
Reference(s)
Primary literature Gómez-Ruiz, J.Á., Ramos, M., Recio, I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. International Dairy Journal. 2002, 12, 697-706.
Other literature(s) N.D
PubDate 2002
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214